ACTIVE

Société Anonyme de Participation et de Gestion

Financial year 2025 · Closed on 30/06/2025

Net result2,7 Md €+5 784,8 %over 1 year
Revenue1,8 M €-66,5 %over 1 year
Equity3 Md €+802,0 %over 1 year
Workforce11,7 ETP+33,0 %over 1 year

Identity

Source · BCE/KBO

Société Anonyme de Participation et de Gestion is a Public limited company incorporated in 1977. Its main activity is: Activities of holding companies. Its registered office is in Ixelles. It employs on average 11,7 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0420.201.921
Incorporation
20/12/1977
Legal form
Public limited company
Registered office
Rue de Livourne 41
1050 Ixelles · BruxellesSee on map
Contributed capital
77 000 000,00 €
Latest accounts
30/06/2025
Average workforce
11,7 ETP
Joint committees (2)
  • 100
  • 218
Signals
ProfitableSolid equityLow riskGood liquidityPositive cashflowHealthy social debtsHigh revenue

Financials

Source · NBB, 20 filings

Trend over 19 financial years

20252024202320222021
Income statement
Revenue1,8 M €5,4 M €5,1 M €4,3 M €2 M €
EBITDA-18,4 M €604,9 k €1,3 M €-529,9 k €-1,3 M €
Operating result-19 M €97,3 k €761,3 k €-974,6 k €-1,7 M €
Net result2,7 Md €45,8 M €35,9 M €30,4 M €15,5 M €
Balance sheet
Equity3 Md €335,1 M €273,7 M €245 M €220,2 M €
Total assets3,1 Md €345,5 M €297,5 M €317 M €265,5 M €
Cash50 M €1,1 M €248,9 k €1,6 M €2,9 M €
Debts27,8 M €10,4 M €23,7 M €71,9 M €45,2 M €
Other
Workforce11,7 ETP8,8 ETP8,5 ETP9,6 ETP9,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

more than 1.000 M€
See the valuation

Board of directors

Source · NBB, accounts to 30/06/2024

6 active · 9 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Denis PETTIAUX
Director20/10/2023 → 16/10/2025
FDA FRANCESCO D'AMICORepresented by Francesco D'AMICO
Director15/02/2021 → 15/10/2026
GEMMS PartnersRepresented by Sophie GASPERMENT
Director19/10/2023 → 16/10/2024
Catheline D'IETEREN
Director17/09/2001 → 16/10/2025
Michel ALLE
Director21/09/2009 → 16/10/2025
Olivier PERIER
Director17/09/2001 → 16/10/2025

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
FDA Francesco D’Amico AGRepresented by Francesco D'Amico
Director15/02/2021 → 2021 accounts
Philippe Bodson
Director20/10/2016 → 04/04/2020
CHC Consulting sarlRepresented by Christian Contzen
Director09/10/2012 → 2018 accounts

Other companies at this address

Rue de Livourne 41 1050 Ixelles
CompanyCBE no.
BATAVES 1521● Active
0895.694.832
0424.517.530
BIO CAP INVEST● Active
0719.433.261
BLANCHE II● Active
0449.007.258
0408.372.869
0870.106.232
0471.846.404
0679.660.786
NAZCA● Active
0838.682.487
0431.204.986

Full financial information

Source · NBB
202520242023202220212020
Type of accountFull modelFull modelFull modelFull modelFull modelFull model
Start of the financial year01/07/202401/07/202301/07/202201/07/202101/07/202001/07/2019
Closing of the financial year30/06/202530/06/202430/06/202330/06/202230/06/202130/06/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date24/12/202528/01/202520/11/202328/10/202210/11/202104/11/2020
General meeting01/12/202502/12/202419/10/202320/10/202221/10/202115/10/2020
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings
ModelClosingGeneral meetingFiledLanguageDocument
Full model30/06/202501/12/202524/12/2025FrenchPDF
Full model30/06/202402/12/202428/01/2025FrenchPDF
Full model30/06/202319/10/202320/11/2023FrenchPDF
Full model30/06/202220/10/202228/10/2022FrenchPDF
Full model30/06/202121/10/202110/11/2021FrenchPDF
Full model30/06/202015/10/202004/11/2020FrenchPDF
Full model30/06/201917/10/201922/10/2019FrenchPDF
Full model30/06/201818/10/201810/12/2018FrenchPDF
Full model30/06/201719/10/201717/11/2017FrenchPDF
Full model30/06/201620/10/201627/10/2016FrenchPDF
Full model30/06/201509/10/201509/11/2015FrenchPDF
Abridged model30/06/201415/09/201401/12/2014FrenchPDF
Abridged model30/06/201316/09/201302/12/2013FrenchPDF
Abridged model30/06/201217/09/201206/12/2012FrenchPDF
Abridged model30/06/201119/09/201120/12/2011FrenchPDF
Abridged model30/06/201022/09/201022/11/2010FrenchPDF
Abridged model30/06/200921/09/200915/12/2009FrenchPDF
Abridged model30/06/200815/09/200803/11/2008FrenchPDF
Abridged model30/06/200717/09/200725/04/2008FrenchPDF
Abridged model30/06/200618/09/200626/01/2007FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

more than 1.000 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2024

6 active · 9 ended

Active mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
Denis PETTIAUX
Director20/10/2023 → 16/10/2025
FDA FRANCESCO D'AMICORepresented by Francesco D'AMICO
Director15/02/2021 → 15/10/2026
GEMMS PartnersRepresented by Sophie GASPERMENT
Director19/10/2023 → 16/10/2024
Catheline D'IETEREN
Director17/09/2001 → 16/10/2025
Michel ALLE
Director21/09/2009 → 16/10/2025
Olivier PERIER
Director17/09/2001 → 16/10/2025

Ended mandates

DirectorMandates in this companyPeriodOther mandatescurrentendedstruck offbankruptcies
FDA Francesco D’Amico AGRepresented by Francesco D'Amico
Director15/02/2021 → 2021 accounts
Philippe Bodson
Director20/10/2016 → 04/04/2020
CHC Consulting sarlRepresented by Christian Contzen
Director09/10/2012 → 2018 accounts

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates30/06/2026
    ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING - BOEKJAAR
    PDF
  • Mandates30/06/2026
    DEMISSIONS, NOMINATIONS - ASSEMBLEE GENERALE - ANNEE COMPTABLE
    PDF
  • Mandates19/11/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates24/01/2024
    DEMISSIONS, NOMINATIONS
    PDF
  • Capital / shares08/01/2024
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Capital / shares08/01/2024
    STATUTS (TRADUCTION, COORDINATION, AUTRES MODIFICATIONS, …) - CAPITAL, ACTIONS
    PDF
  • Mandates28/02/2023
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates01/09/2022
    DEMISSIONS, NOMINATIONS
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts
Year
Identity
Incorporation
Name
Registered office
Annual accounts
Filings19 filings
Mandates
Denis PETTIAUX
FDA FRANCESCO D'AMICO
GEMMS Partners
Olivier PERIER
Michel ALLE
Catheline D'IETEREN
FDA Francesco D’Amico AG
Philippe BODSON
CHC Consulting sarl
Christian Contzen
sprl NAZCA
Maurice Périer
19771978197919801981198219831984198519861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202420252026
Société Anonyme de Participation et de Gestion
Rue de Livourne 41, 1050 Ixelles
Director
Director
Director
Director
Director
Director
Director
Director
Chairman of the board of directorsDirector
CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE
Registered addressPeriodSource
Rue de Livourne 41, 1050 IxellesCurrent
accounts 2022 → 2024
Accounts 2024 · 2025-00016402

Company names

Source · NBB annual accounts, CBE
NamePeriodSource
Société Anonyme de Participation et de GestionCurrent
accounts 2007 → 2025
Accounts 2025 · 2025-00591733

Events

  1. 2025
    Annual accounts 20252,7 Md €↑
  2. 17/10/2024
    nominationCatheline d'leteren · Administrateur
  3. 17/10/2024
    nominationOlivier Périer · Administrateur
  4. 17/10/2024
    nominationMichel Allé · Administrateur
  5. 17/10/2024
    nominationDenis Pettiaux · Administrateur
  6. 17/10/2024
    nominationFDA Francesco D'Amico AG · Administrateur
  7. 2024
    Annual accounts 202445,8 M €↑
  8. 05/12/2023
    nominationOlivier Périer · membre du comité exécutif
  9. 05/12/2023
    nominationRabotat sr · membre du comité exécutif
  10. 19/10/2023
    nominationGemms Partners · administrateur
  11. 19/10/2023
    nominationMazars Réviseurs d'Entreprises — Bedrijfsrevisoren · commissaire
  12. 2023
    Annual accounts 202335,9 M €↑
  13. 20/10/2022
    nominationDenis PETTIAUX · administrateur
  14. 05/10/2022
    nominationOlivier Périer · président du conseil
  15. 05/10/2022
    nominationMichel Allé · vice-président du conseil
  16. 2022
    Annual accounts 202230,4 M €↑
  17. 2021
    Annual accounts 202115,5 M €↑
  18. 2020
    Annual accounts 20203 M €↓
  19. 2019
    Annual accounts 201916,4 M €↓
  20. 2018
    Annual accounts 201836,7 M €↑
  21. 2017
    Annual accounts 201715,8 M €↑
  22. 2016
    Annual accounts 201611,3 M €↑
  23. 2015
    Annual accounts 20159,5 M €↓
  24. 2014
    Annual accounts 20149,6 M €↑
  25. 2013
    Annual accounts 20137,9 M €↓
  26. 2012
    Annual accounts 20129,4 M €↑
  27. 2011
    Annual accounts 20114,6 M €↑
  28. 2010
    Annual accounts 20103,3 M €↓
  29. 2009
    Annual accounts 20093,9 M €↑
  30. 2008
    Annual accounts 20083,7 M €↑
  31. 2007
    Annual accounts 20073,4 M €
  32. 20/12/1977
    IncorporationPublic limited company